
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : PDS0203
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Recipient : PDS Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable
PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine
Details : PDS Biotech and Farmacore have jointly prioritized advancement of PDS0203 to human clinical trials. PDS Biotech had previously announced the parallel development of two Versamune®-based COVID-19 vaccines PDS0203 and PDS0204 each containing different SAR...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
November 10, 2020
Lead Product(s) : PDS0203
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Recipient : PDS Biotechnology
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : PDS0204
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Mctic
Deal Size : Undisclosed
Deal Type : Agreement
PDS Biotech and Farmacore Partner to Develop Covid-19 Vaccine
Details : Under the collaboration, PDS Biotech and Farmacore will accelerate development of Versamune®-CoV-2FC into Phase 1 clinical testing in Brazil, with initial financial support provided by the Brazilian Ministry of Science, Technology, Innovation and Commun...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
June 17, 2020
Lead Product(s) : PDS0204
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Mctic
Deal Size : Undisclosed
Deal Type : Agreement
